0001562180-21-003670.txt : 20210520
0001562180-21-003670.hdr.sgml : 20210520
20210520164620
ACCESSION NUMBER: 0001562180-21-003670
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210518
FILED AS OF DATE: 20210520
DATE AS OF CHANGE: 20210520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Egros Fabrice
CENTRAL INDEX KEY: 0001597085
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37708
FILM NUMBER: 21945086
MAIL ADDRESS:
STREET 1: C/O SYNDAX PHARMACEUTICALS, INC.
STREET 2: TOTTEN POND ROAD, SUITE 140
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001395937
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320162505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-419-1400
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-05-18
false
0001395937
Syndax Pharmaceuticals Inc
SNDX
0001597085
Egros Fabrice
C/O SYNDAX PHARMACEUTICALS, INC.
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3
WALTHAM
MA
02451
true
false
false
false
Common Stock
2021-05-18
4
M
false
11926.00
7.20
A
27926.00
D
Common Stock
2021-05-18
4
M
false
1683.00
7.88
A
29609.00
D
Common Stock
2021-05-18
4
S
false
11926.00
18.6482
D
17683.00
D
Common Stock
2021-05-18
4
S
false
1683.00
18.6482
D
16000.00
D
Stock Options (Right to buy)
7.88
2021-05-18
4
M
false
1683.00
0.00
D
2029-06-10
Common Stock
0.00
0.00
D
Stock Options (Right to buy)
7.20
2021-05-18
4
M
false
11926.00
0.00
D
2025-08-18
Common Stock
0.00
0.00
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 93,317 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested.
This option is fully vested.
/s/ Michael A. Metzger, Attorney-in-Fact
2021-05-20